Literature DB >> 6104724

Differential inhibiton of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses in pithed rats.

I Yamaguchi, I J Kopin.   

Abstract

The relative potencies of alpha adrenoceptor antagonists at pre- and postsynaptic receptors were assessed by comparing their effects on increments in plasma norepinephrine levels and blood pressure during stimulation of the sympathetic outflow from the spinal cord of pithed rats. Since increments in blood pressure are related to the logarithms of increases in plasma norepinephrine, the latter appear to reflect levels of the catecholamine at vascular alpha receptors. Phenoxybenzamine, dibenamine and chlorpromazine were found to block preferentially postsynaptic alpha receptors, phentolamine and tolazoline were nearly equipotent at pre- and postsynaptic receptors and mianserin and piperoxan were more potent inhibitors of presynaptic alpha receptors. Phenoxybenzamine and dibenamine were much more effective in blocking the pressor responses to sympathetic stimulation than administered norepinephrine. The opposite was true of mianserin and piperoxan, whereas phentolamine appeared to be about equipotent in blocking the pressor response to stimulation and norepinephrine. These results suggest that the pressor effects of administered norepinephrine is mediated by different receptors (alpha-2-type) than is the pressor response to stimulation of the sympathetic outflow which appears to be mediated by alpha-1-type adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6104724

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

1.  Differential effects of calcium antagonists and Bay K 8644 on contractile responses to exogenous noradrenaline and adrenergic nerve stimulation in the rabbit ear artery.

Authors:  T V Skärby; E D Högestätt
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

2.  Phaeochromocytoma: a catecholamine and oxidative stress disorder.

Authors:  K Pacak
Journal:  Endocr Regul       Date:  2011-04

3.  Assessment of alpha-adrenergic receptor subtypes in isolated rat aortic segments.

Authors:  R A Macia; W D Matthews; J Lafferty; R M DeMarinis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

4.  Sympathetic modulation of cold-receptive neurones in the trigeminal system of the rat.

Authors:  S N Davies
Journal:  J Physiol       Date:  1985-09       Impact factor: 5.182

5.  alpha 1-Adrenoceptor subtype mediating contraction of the smooth muscle in the lower urinary tract and prostate of rabbits.

Authors:  K Honda; A Miyata-Osawa; T Takenaka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-07       Impact factor: 3.000

6.  alpha-Adrenoceptor blocking properties of raubasine in pithed rats.

Authors:  P Demichel; P Gomond; J Roquebert
Journal:  Br J Pharmacol       Date:  1982-11       Impact factor: 8.739

7.  Selective alpha 1- and alpha 2-adrenoceptor agonist-induced contractions and 45Ca fluxes in the rat isolated aorta.

Authors:  T Godfraind; R C Miller; J S Lima
Journal:  Br J Pharmacol       Date:  1982-12       Impact factor: 8.739

8.  Frequency- and train length-dependent variation in the roles of postjunctional alpha 1- and alpha 2-adrenoceptors for the field stimulation-induced neurogenic contraction of rat tail artery.

Authors:  J X Bao; F Gonon; L Stjärne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

9.  Estimation of intrasynaptic norepinephrine concentrations at vascular neuroeffector junctions in vivo.

Authors:  I J Kopin; Z Zukowska-Grojec; M A Bayorh; D S Goldstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

10.  Involvement of alpha 1- and alpha 2-adrenoceptors in the responses of proximal and distal segments of the canine saphenous vein to exogenous and endogenous noradrenaline.

Authors:  O Pereira; D Moura; P Nunes; M J Vaz-da Silva; S Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.